OMIDRIA
Drug
Omeros Corporation
Total Payments
$896,672
Transactions
1,641
Doctors
846
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $106,335 | 43 | 32 |
| 2022 | $51,359 | 24 | 18 |
| 2021 | $140,894 | 121 | 65 |
| 2020 | $58,310 | 130 | 97 |
| 2019 | $216,765 | 541 | 325 |
| 2018 | $102,249 | 227 | 152 |
| 2017 | $220,760 | 555 | 360 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $339,978 | 154 | 37.9% |
| Consulting Fee | $157,628 | 47 | 17.6% |
| Honoraria | $139,950 | 48 | 15.6% |
| Food and Beverage | $109,751 | 1,101 | 12.2% |
| Travel and Lodging | $73,388 | 277 | 8.2% |
| Education | $45,456 | 8 | 5.1% |
| Unspecified | $20,521 | 4 | 2.3% |
| Grant | $10,000 | 2 | 1.1% |
Payments by Type
General
$876,151
1,637 transactions
Research
$20,521
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| OMS302-ILR-007 | Omeros Corporation | $20,521 | 0 |
Top Doctors Receiving Payments for OMIDRIA — Page 34
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Ophthalmology | Birmingham, AL | $53.07 | 1 |
| David Gerkin | — | Knoxville, TN | $53.07 | 1 |
| , M.D | Specialist | Marshall, TX | $53.07 | 1 |
| , MD | Ophthalmology | Gallatin, TN | $53.07 | 1 |
| , M.D | Glaucoma Specialist | Decatur, GA | $53.07 | 1 |
| , M.D | Ophthalmology | Nashville, TN | $53.07 | 1 |
| , M.D | Ophthalmology | Evansville, IN | $52.12 | 1 |
| , M.D | Ophthalmology | Evansville, IN | $52.12 | 1 |
| , M.D | Ophthalmology | Evansville, IN | $52.12 | 1 |
| Jon Perkins | — | Evansville, IN | $52.12 | 1 |
| , M.D | Ophthalmology | Evansville, IN | $52.12 | 1 |
| , MD | Ophthalmology | Evansville, IN | $52.12 | 1 |
| , MD | Retina Specialist | Evansville, IN | $52.12 | 1 |
| , MD | Ophthalmology | Evansville, IN | $52.12 | 1 |
| , M.D | Ophthalmology | Abilene, TX | $42.25 | 1 |
| , MD | Ophthalmology | Abilene, TX | $42.25 | 1 |
| , M.D | Ophthalmology | New York, NY | $30.00 | 1 |
| , M.D | Ophthalmology | Ridgewood, NJ | $30.00 | 1 |
| , M.D | Ophthalmology | Irvington, NJ | $30.00 | 1 |
| , MD | Specialist | Oakland, NJ | $30.00 | 1 |
| , MD | Ophthalmology | New York, NY | $30.00 | 1 |
| , M.D | Ophthalmology | Troy, OH | $16.40 | 1 |
Ad
Manufacturing Companies
- Omeros Corporation $738,978
- Rayner Intraocular Lenses Limited $157,694
Product Information
- Type Drug
- Total Payments $896,672
- Total Doctors 846
- Transactions 1,641
About OMIDRIA
OMIDRIA is a drug associated with $896,672 in payments to 846 healthcare providers, recorded across 1,641 transactions in the CMS Open Payments database. The primary manufacturer is Omeros Corporation.
Payment data is available from 2017 to 2023. In 2023, $106,335 was paid across 43 transactions to 32 doctors.
The most common payment nature for OMIDRIA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($339,978, 37.9% of total).
OMIDRIA is associated with 1 research study, including "OMS302-ILR-007" ($20,521).